• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

You’d like to be regularly informed on the latest developments in Good Manufacturing Practices?

 

Subscribe to our free GMP Newsletter LOGFILE!

>>> REGISTER NOW

The New USP <1231>
Water for Pharmaceutical Purposes

a detailed Overview

>>> ORDER NOW

Award for the
GMP MANUAL

GMP knowledge that convinces.

Image

On 7 June 2016 Maas & Peither GMP Publishing has received a

SIPAward in the category
"Best New Success Story" and was awarded with the 3rd place.

The GMP MANUAL impressed the jury with "Save Drugs through Better GMP Understanding".


GMP MANUAL

GMP in Practice: 24 chapters written by internationally renowned industry experts.

 

GMP Regulations: 8 chapters with the most important GMP guidelines and regulations.

 

Image

>>> READ MORE

TOP 5 GMP Downloads

1. GMP Fundamentals
A quick and comprehensive overview of the complex world of GMP.

 

2. GDP Audit Checklist

More than 700 questions with reference to regulations.

 

3. How to design a Laboratory Data Management System
Practical strategies for designing and implementing an LDMS.


4. Industry Guide to handle OOX Test Results
A concise overview of the OOX process.

 

5. GMP Compliance Basics of Packaging Materials and Processes
Are you on top of the best practices you need to design and create your packaging correctly — every time?

 

>>> More Downloads

News about GMP/cGMP

EMA: Work Plan 2012

The European Medicines Agency (EMA) released the work programme for 2012.

 

In 2012 the Agency will focus on the following topics:

  • Implementing new pharmacovigilance legislation
  • Implementing revised policies on handling conflicts on interests
  • Ethical and practical GCP (Good Clinical Practice) aspects of clinical trials
  • Progress of Agency interactions with healthcare professionals
  • Supply shortages of medicines caused by insufficient GMP compliance. EMAs Management Board initiated the discussion on a "Reflection paper on medicinal product supply shortages caused by manufacturing/GMP compliance problems".
Outcome:

EMA will publish a detailled work plan in January 2012. The "Reflection paper on ethical and GCP aspects of clinical trials of medicinal products for human use conducted outside of the EU/EEA and submitted in marketing authorisation applications to the EU regulatory authorities" will be presented to the Heads of Medicines Agencies for endorsement in February 2012 as a final step.

Source:

EMA/ Announcement

 

Comments
No comment has yet been written about this news.